Teva Pharmaceutical Industries Limited
TEVA
Classement en actions
#13238
Teva Pharmaceutical Industries Limited operates as a prominent global... Teva Pharmaceutical Industries Limited operates as a prominent global pharmaceutical firm, involved in the research, development, manufacturing, marketing, and distribution of generic, specialized, and biopharmaceutical products throughout North America, Europe, and other international regions. The company's diverse portfolio encompasses sterile preparations, hormonal therapies, high-potency drugs, and cytotoxic substances, supplied in a wide array of dosage forms such as tablets, capsules, injectable solutions, inhalants, oral liquids, transdermal patches, topical ointments, and creams. Furthermore, Teva develops, produces, and sells active pharmaceutical ingredients (APIs). A significant portion of its research and product development is concentrated on the central nervous system, pain management, respiratory illnesses, and oncology. Leading products for the central nervous system include Copaxone, utilized for relapsing multiple sclerosis; AJOVY, an option for migraine prevention; and AUSTEDO, prescribed for tardive dyskinesia and chorea linked to Huntington's disease. Within the respiratory domain, addressing asthma and chronic obstructive pulmonary disease, Teva offers products like ProAir, QVAR, various Digihaler and RespiClick formulations, along with BRALTUS and CINQAIR/CINQAERO. Their oncology division features treatments such as Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company also collaborates with MedinCell on the creation and commercialization of multiple extended-release injectable products, including a risperidone suspension designed for individuals with schizophrenia. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.
Prix de l'action
$41.51
Dernière synchronisation: 2026-10-16
Capitalisation boursière
$483.77M
Changement (1 jour)
-0.85%
Changement (1 an)
107.47%
Pays
IL
Échange Teva Pharmaceutical Industries Limited (TEVA)
Catégorie
Healthcare
Capitalisation boursière de Teva Pharmaceutical Industries Limited(TEVA)
Capitalisation boursière: $483.77M
En October 2026, Teva Pharmaceutical Industries Limited a une capitalisation boursière de $483.77M. Cela fait de Teva Pharmaceutical Industries Limited la 13238th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Teva Pharmaceutical Industries Limited du 2010 au 2026
TEVA par rapport au top 5 des plus populaires stocks
